Pipette Diaper Rash Cream

Pipette Diaper Rash by

Drug Labeling and Warnings

Pipette Diaper Rash by is a Otc medication manufactured, distributed, or labeled by Amyris, Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

PIPETTE DIAPER RASH- zinc oxide cream 
Amyris, Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Pipette Diaper Rash Cream

Active Ingredients

  Zinc Oxide 14%

Purpose

Ski Protectant

Uses

  • helps treat and prvent diaper rash
  • protects chafed skin due to diaper rash and helps seal out wetness

Warnings

  • For external use only

When using this product

  • do not get into eyes

Stop use and aks a doctor if

  •   condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  •   Change wet and soiled diapers promptly
  • cleanse the diaper area
  • allow to dry
  • apply cream liberally as often as necessary, with each diaper change, and especially at betime or any time when exposure to wet diapers may be prolonged.

Other information

Protect this product from excessive heat and direct sunlight

Inactive Ingredients

Glycerin, Squalane, Butyrospermum Parkii (Shea ) Butter, Jojoba Esters, Euterpe Oleracea Sterols,
Polyglyceryl-2 Dipolyhydroxystearate, Sorbitan Olivate, 1,2-Hexandiol, Caprylyl Glycol, Bisabolol, Linoleic Acid, Oleic
Acid, Linolenic Acid, Tocopherol.

DiaperCrmUC

PIPETTE DIAPER RASH 
zinc oxide cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 73517-427
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION14 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
SQUALANE (UNII: GW89575KF9)  
BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES (UNII: 0C9AC7D6XU)  
HYDROGENATED JOJOBA OIL/JOJOBA OIL, RANDOMIZED (IODINE VALUE 40-44) (UNII: AS2SZ9757N)  
EUTERPE OLERACEA WHOLE (UNII: Y57H6218HP)  
POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE (UNII: 9229XJ4V12)  
SORBITAN OLIVATE (UNII: MDL271E3GR)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
LEVOMENOL (UNII: 24WE03BX2T)  
LINOLEIC ACID (UNII: 9KJL21T0QJ)  
OLEIC ACID (UNII: 2UMI9U37CP)  
LINOLENIC ACID (UNII: 0RBV727H71)  
TOCOPHEROL (UNII: R0ZB2556P8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 73517-427-021 in 1 CARTON02/01/2021
1NDC: 73517-427-0188.7 mL in 1 TUBE; Type 0: Not a Combination Product
2NDC: 73517-427-0330 mL in 1 TUBE; Type 0: Not a Combination Product02/01/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM01602/01/2021
Labeler - Amyris, Inc (185930182)

Revised: 11/2022
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.